Sort

Search

01/06/2025 Delphi consensus on referral criteria for pediatric patients with suspected Dravet syndrome
Aledo-Serrano, A, Boronat, S, García-Peñas, JJ, García-Ron, A, Gil-Nagel, A, Uranga, JJR, Sánchez-Carpintero, R, Smeyers, P, Villanueva, V. Delphi consensus on referral criteria for pediatric patients with suspected Dravet syndrome. EPILEPSY & BEHAVIOR. 2025; 167DOI:10.1016/j.yebeh.2025.110401. PMID:40158412. IF:2.300(Q2/4D).
01/06/2025 Telemedicine in critical care
Spies, CD, Ranzani, OT. Telemedicine in critical care. INTENSIVE CARE MEDICINE. 2025; 51(6)DOI:10.1007/s00134-025-07955-5. PMID:40471258. IF:21.200(Q1/1D).
01/06/2025 Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on Thrombosis
Paradies, V, Masiero, G, Rubboli, A, Van Beusekom, HMM, Costa, F, Capranzano, P, Degrauwe, S, Gorog, DA, Jorge, CM, Buchanan, GL, Alasnag, M, Trabattoni, D, Fraccaro, C, Sibbing, D, Dudek, D, Vilahur, G, Chieffo, A, Mehran, R, Capodanno, D, Barbato, E, Siller-Matula, JM. Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on Thrombosis. EuroIntervention. 2025; 21(12)DOI:10.4244/EIJ-D-24-00876. PMID:40388110. IF:9.500(Q1/1D).
01/06/2025 Comprehensive Clinical and Genetic Characterization of a Spanish Cohort of 22 Patients With Bainbridge-Ropers Syndrome
Trujillano, L, Valenzuela, I, Costa-Roger, M, Cusco, I, Fernandez-Alvarez, P, Cueto-Gonzalez, A, Lasa-Aranzasti, A, Masotto, B, Abuli, A, Codina-Sola, M, del Campo, M, Moreno, JAR, Dominguez, CP, Milla, CP, de la Fuente, RP, Quesada-Espinosa, JF, Nunez-Enamorado, N, Gener, B, Ballesta-Martinez, MJ, Brea-Fernandez, AJ, Fernandez-Prieto, M, Trujillo-Quintero, JP, Ruiz, A, Santos-Simarro, F, Rosello, M, Orellana, C, Martinez, F, Martinez-Monseny, AF, Casas-Alba, D, Serrano, M, Palomares-Bralo, M, Rikeros-Orozco, E, Gomez-Cano, MA, Tirado-Requero, P, Juste, JP, Ramos, FJ, Garcia-Arumi, E, Tizzano, EF. Comprehensive Clinical and Genetic Characterization of a Spanish Cohort of 22 Patients With Bainbridge-Ropers Syndrome. CLINICAL GENETICS. 2025; 107(6)DOI:10.1111/cge.14701. PMID:39833101. IF:2.300(Q3/6D).
01/06/2025 Effects of Chronic High-Fat Diet and Pemafibrate Treatment on Stroke Outcomes
Chaparro-Cabanillas, N, Pedragosa, J, Núñez-Moyano, H, Escolà-Gil, JC, Planas, AM. Effects of Chronic High-Fat Diet and Pemafibrate Treatment on Stroke Outcomes. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2025; 45(1)DOI:. PMID:. IF:4.500(Q1/2D).
01/06/2025 Regression of pre-existing white matter hyperintensities after CD19 CAR Tcell induced ICANS: A case series
Borrell-Pichot, M, Lozano, A, Granell, E, Caballero, A, Briones-Mejide, J, Caballero-Avila, M, Vidal-Jordana, A, Querol, L, Mart n-Aguilar, L. Regression of pre-existing white matter hyperintensities after CD19 CAR Tcell induced ICANS: A case series. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).
01/06/2025 Exploring results of mechanical thrombectomy in nonagenarians with ischaemic stroke and anterior circulation occlusion
Delgado-Romeu, M, Lopez-Lombardia,O, Carbonell-Fern ndez, P, Morales-Gonz lez, C, Borrell-Pic, M, Martinez-Dome o, A, Guasch-Jim nez, M, Ezcurra-D az, G, Fern ndez-Vidal, J, Prats-S nchez, L, Ramos-Pachn, A, Marti-Fabregas, J, Camps-Renom, P, Lambea-Gil, A. Exploring results of mechanical thrombectomy in nonagenarians with ischaemic stroke and anterior circulation occlusion. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).
01/06/2025 Exploring gender disparities in neurology education: Insights from Spanish medical schools
Lambea-Gil, A, Gil-Navarro, S, Jim nez, M, Mart nez-S nchez, P, Mir, P, Oreja-Guevara, C, Pascual-Gomez, J, P rez-Sempere, A, Santos-Lasaosa, S, Frank-Garc a, A, D ez-Tejedor, E. Exploring gender disparities in neurology education: Insights from Spanish medical schools. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).
01/06/2025 End-of-life and palliative sedation in the neurology inpatient unit of a tertiary hospital
Morales-Gonz lez, C, Lambea-Gil, A, Barroeta-Espar, I, Olmedo-Saura, G, Prats-S nchez, L, Ramos-Pachon, A, Ros-Castello, V, Vesperina-Castro, A, Mart nez-Dome o, A. End-of-life and palliative sedation in the neurology inpatient unit of a tertiary hospital. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).
01/06/2025 Neurophobia and the perception of neurology among neurologists in Spain
Saldana-Inda, I, Lambea-Gil, A. Neurophobia and the perception of neurology among neurologists in Spain. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).
01/06/2025 Exploring the Association of Cerebral Vasoreactivity in Patients with Acute Intracerebral Hemorrhage with Functional Outcomes
García, JM, Gil, AL, Pachón, AR, Díaz, GE, Jiménez, MG, Renom, PC, Gómez, MI, Frisk, LK, Vega, CF, Zanoletti, M, Simón, AA, Fabrega, CG, Grifol, NP, Chorro, IM, Sánchez, LP, Vidal, JMF, Fernandez, JJS, Fabregas, JM, Durduran, T. Exploring the Association of Cerebral Vasoreactivity in Patients with Acute Intracerebral Hemorrhage with Functional Outcomes. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2025; 45(1)DOI:. PMID:. IF:4.500(Q1/2D).
01/06/2025 Safety and efficacy data from the phase 2 ARDA study of empasiprubart in multifocal motor neuropathy
Querol, L, Harbo, T, Peric, S, Hussain, Y, Cadour, S, van de Walle, I, Persson, E, Vujcic, M, van de Steen, O, Allen, J, Orazio, EN, Attarian, S, Karam, C, Katzberg, H, Stettner, M, Rinaldi, S, van der Pol, W. Safety and efficacy data from the phase 2 ARDA study of empasiprubart in multifocal motor neuropathy. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).
01/06/2025 Safety and efficacy of riliprubart in chronic inflammatory demyelinating polyneuropathy: 76-week phase 2 trial results
Querol, L, Lewis, RA, Hartung, HP, van Doorn, PA, Lin, J, Dionne, A, Attarian, S, Wallstroem, E, Auwarter, K, Lu, Y, Alonso, MA, Atassi, N, Hughes, RAC. Safety and efficacy of riliprubart in chronic inflammatory demyelinating polyneuropathy: 76-week phase 2 trial results. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).
01/06/2025 Effect of efgartigimod PH20 SC on lower limb function in chronic inflammatory demyelinating polyneuropathy in ADHERE
Rinaldi, S, Allen, J, Lin, J, Stettner, M, Merkies, I, Guptill, J, Hewamadduma, C, Istas, G, De Roeck, A, Kuwabara, S, Lauria, G, Querol, L, Suresh, N, Karam, C, Skripuletz, T, Echaniz-Laguna, A, Van Hoorick, B, Yamasaki, R, Lewis, R, van Doorn, P. Effect of efgartigimod PH20 SC on lower limb function in chronic inflammatory demyelinating polyneuropathy in ADHERE. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).
01/06/2025 Proteomic profiling of Guillain-Barre Syndrome using aptamers: Identifying and Validating Potential Biomarkers
Collet-Vidiella, R, Aguilar, LM, Lleix , C, Caballero-Avila, M, Illa, CT, Go i, EP, Llarch, P, Lluci -Carol, L, Tous, MS, Casasnovas, C, Guti rrez-Guti rrez, G, Fern ndez, JP, Carbayo, A, Gallardo, E, Vesperinas, A, Llanso, L, Fern ndez-Cadenas, I, Querol, L. Proteomic profiling of Guillain-Barre Syndrome using aptamers: Identifying and Validating Potential Biomarkers. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).
01/06/2025 Chat-GPT-4o in diagnosis and management of real-life polyneuropathy cases: Comparative analysis with neurologists
De Lorenzo, A, Moretti, G, Bertini, A, Collet-Vidiella, R, Fasolino, A, Fortanier, E, Hadden, R, Islam, B, Kleopa, K, Cejas, LL, Leonardi, L, Mira, V, Peric, S, Rajabally, Y, Sevilla, T, Tomaselli, P, Tozza, S, Pisciotta, C, Pareyson, D, Nobile-Orazio, E, Doneddu, P. Chat-GPT-4o in diagnosis and management of real-life polyneuropathy cases: Comparative analysis with neurologists. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).
01/06/2025 Immune checkpoint inhibitor-related myositis-myasthenia: A retrospective cohort study in Spain
Hernandez, EM, Maqueda, JC, Fonseca, E, Marco, C, Chico, J, Fernandez, JG, Llaurado, A, Cabello, J, del Pino, L, Izquierdo, C, Cortes, E, G llego, J, Ros, M, Cald , R, Pelayo, A, Vizcaino, CS, Hernandez, H, Alvarez, J, Simo, M, Dalmau, J, Bruna, J, Velasco, R. Immune checkpoint inhibitor-related myositis-myasthenia: A retrospective cohort study in Spain. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).
01/06/2025 Efficacy of Riliprubart in chronic inflammatory demyelinating polyneuropathy: Phase 2 subgroup analyses
Lewis, RA, Querol, L, Hartung, HP, van Doorn, PA, Lin, J, Dionne, A, Attarian, S, Wallstroem, E, Lu, Y, Alonso, MA, Atassi, N, Hughes, AC. Efficacy of Riliprubart in chronic inflammatory demyelinating polyneuropathy: Phase 2 subgroup analyses. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).
01/06/2025 Managing multifocal motor neuropathy: A survey of neurologists from Japan, Canada, and six European countries
Querol, L, Lewis, R, Sommer, C, Bromberg, M, Barrera-Sierra, S, Arvin-Berod, C, Nisbet, P, Gelinas, D, Guptill, J, Wood, J. Managing multifocal motor neuropathy: A survey of neurologists from Japan, Canada, and six European countries. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).
01/06/2025 Psychometric evaluation of resistance to change questionnaire: reluctance to adopt new treatments in myasthenia gravis
Reyes, V, Maurino, J, Armangu , T, Querol, L, Guti rrez-Guti rrez, G, Sotoca, J, Ares, A, Villaverde, R, Salas, E, D az-Abos, P, Cort s-Vicente, E, Gomez-Ballesteros, R, Ballesteros, J. Psychometric evaluation of resistance to change questionnaire: reluctance to adopt new treatments in myasthenia gravis. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).